The Generic Central Nervous System Drugs market size is expected to reach $132.44 billion in 2030 at a CAGR of 7.2%, driven by rising incidence of mental health disorders.
Read More
The General Anesthesia Drugs market size is expected to reach $6.16 billion in 2030 at a CAGR of 3.6%, driven by increasing volume of surgical procedures.
Read More
The Gene-Editing Transfection Chemicals market size is expected to reach $1.56 billion in 2030 at a CAGR of 7.7%, driven by accelerated research in gene therapy.
Read More
The Gene-Circuit Cell Therapy market size is expected to reach $3.56 billion in 2030 at a CAGR of 20.8%, driven by growing adoption of personalized medicine.
Read More
The Gene Therapy on Neurological Diseases market size is expected to reach $6.48 billion in 2030 at a CAGR of 12.7%, driven by rising neurological disorder prevalence.
Read More
The Gene Therapy for Parkinson’s Disease market size is expected to reach $2.05 billion in 2030 at a CAGR of 26.0%, driven by growing interest in personalized medicine.
Read More
The Gene Therapy for Inherited Genetic Disorders market size is expected to reach $9.69 billion in 2030 at a CAGR of 19.0%, driven by rising personalized medicine demand.
Read More
The Gene Therapy market size is expected to reach $35.61 billion in 2030 at a CAGR of 13.5%, driven by rising healthcare industry investment.
Read More
The global Gene Synthesis market size is expected to reach $10.44 billion in 2030 at a CAGR of 21.7%, driven by rising biofuel demand.
Read More
The Gene Silencing market size is expected to reach $12.1 billion in 2030 at a CAGR of 12.6%, driven by rising prevalence of genetic disorders.
Read More